SciSparc Enters into Definitive Agreement for the Acquisition of a Publicly Traded Company on the TSXV to which it will transfer its Advanced Clinical Stage Pharmaceutical Portfolio

TSX Today: What to Watch for in Stocks on Wednesday, October 15

TSX Growth Companies With High Insider Ownership In October 2025

S&P/TSX soars, closing more than 500 points higher while U.S. markets end mixed

Wall Street ends mixed but TSX sharply higher in catch-up rally

S&P/TSX composite up more than 400 points while U.S. stock markets move lower